Summary by Moomoo AI
David M. Rubenstein, a director at Moderna, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as required by Section 16(a) of the Securities Exchange Act of 1934. The filing, dated 08/05/2024, indicates that Rubenstein does not beneficially own any non-derivative or derivative securities of the company. The form, signed by attorney-in-fact Brian Sandstrom on 08/07/2024, confirms Rubenstein's status as a director and not a 10% owner, officer, or any other role that would require additional disclosure. This standard filing is part of the regulatory requirements for individuals in Rubenstein's position and does not indicate any immediate change in ownership or management structure at Moderna.